Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)

European Journal of Medicinal Chemistry
2023.0

Abstract

By combining docking and molecular dynamics simulations, we explored a library of 65 mostly axially naphthylisoquinoline alkaloids and their analogues, with most different molecular architectures and structural analogues, for their activity against SARS-CoV-2. Although natural biaryls are often regarded without consid-eration of their axial chirality, they can bind to protein targets in an atroposelective manner. By combining docking results with steered molecular dynamics simulations, we identified one alkaloid, korupensamine A, atropisomer-specifically inhibited the main protease (Mpro) activity of SARS-CoV-2 significantly in comparison the reference covalent inhibitor GC376 (IC50 = 2.52 +/- 0.14 and 0.88 +/- 0.15 mu M, respectively) and reduced growth by five orders of magnitude in vitro (EC50 = 4.23 +/- 1.31 mu M). To investigate the binding pathway mode of interaction of korupensamine A within the active site of the protease, we utilized Gaussian accelerated molecular dynamics simulations, which reproduced the docking pose of korupensamine A inside the active

Knowledge Graph

Similar Paper

Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
European Journal of Medicinal Chemistry 2023.0
A Computational Study of Carbazole Alkaloids from Murraya koenigii as Potential SARS-CoV-2 Main Protease Inhibitors
Applied Biochemistry and Biotechnology 2023.0
Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors
Marine Drugs 2022.0
Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors
Bioorganic & Medicinal Chemistry Letters 2022.0
Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
Journal of Natural Products 2023.0
Indole alkaloids as potential candidates against COVID-19: an in silico study
Journal of Molecular Modeling 2022.0
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
Journal of Medicinal Chemistry 2022.0
Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach
Frontiers in Molecular Biosciences 2022.0
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
ACS Medicinal Chemistry Letters 2022.0
Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach
Journal of Chemistry 2021.0